Cholinergic mechanisms in the human uterus.
D000109:Acetylcholine / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001341:Autonomic Nervous System / Q000502:physiology; D001949:Bretylium Compounds / Q000494:pharmacology; D004357:Drug Synergism; D004558:Electric Stimulation; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D010275:Parasympathetic Nervous System / Q000502:physiology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011247:Pregnancy; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D014599:Uterus / Q000187:drug effects / Q000294:innervation*
D001949:Bretylium Compounds; D005730:Ganglionic Blockers; D010879:Piperazines; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D010643:Phenoxybenzamine; D001285:Atropine; D010830:Physostigmine; D000109:Acetylcholine